MTOR inhibitor-18
MTOR inhibitor-18 (Example 106) is a mTOR inhibitor. mTOR inhibitor-18 can be used for mTOR related research, such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders[1].
Product Specifications
CAS Number
2170358-67-3
UNSPSC
12352005
Target
MTOR
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mtor-inhibitor-18.html
Solubility
10 mM in DMSO
Smiles
S=C(NC1=CC=C(C2=NN3C=CC=C3C(N4CCOCC4)=N2)C=C1)NC5=CC=CN=C5
Molecular Formula
C22H21N7OS
Molecular Weight
431.51
References & Citations
[1]Chuangxin GUO, et al. Mechanistic target of rapamycin signaling pathway inhibitors and therapeutic applications. WO2017219800. thereof.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Histone H1 (AE-4), CF488A conjugate, 0.1mg/mL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF640R conjugate, 0.1mg/mL
